Racial and ethnic disparities in acuity of presentation among children with newly diagnosed acute leukemia.
Lena E WinestoneKelly D GetzYimei LiEvanette BurrowsMichael E ScheurerVicky TamM Monica GramatgesJennifer J WilkesTamara P MillerAlix E SeifKaren R RabinBrian T FisherRichard AplencPublished in: Pediatric blood & cancer (2023)
We evaluated disparities in disease burden, organ dysfunction, vital signs, and timing of therapy in children newly presenting with acute leukemia. Among 899 patients with acute leukemia diagnosed at two large children's hospitals, a priori lab-based definitions of high disease burden, infection risk, renal dysfunction, and coagulopathy were applied to electronic health record data. Black patients with acute myeloid leukemia had increased prevalence of elevated white blood cell count and uric acid; Black patients with acute lymphoblastic leukemia demonstrated increased prevalence of coagulopathy. Black patients' presentation more frequently included multiple lab abnormalities consistent with advanced physiologic dysfunction. No differences were found in days to therapy initiation.
Keyphrases
- newly diagnosed
- electronic health record
- uric acid
- acute lymphoblastic leukemia
- acute myeloid leukemia
- young adults
- risk factors
- end stage renal disease
- oxidative stress
- metabolic syndrome
- allogeneic hematopoietic stem cell transplantation
- ejection fraction
- case report
- healthcare
- chronic kidney disease
- peritoneal dialysis
- stem cells
- machine learning
- single cell
- mesenchymal stem cells
- adverse drug
- artificial intelligence
- affordable care act
- health insurance